youtube_live
Q3 2026 earnings • 12:00 AM tomorrow
See detailschevron_right
INSP:NYSE
Inspire Medical Systems Inc
$68.10
arrow_downward
-4.33%(-3.08) 1D
Oct 30, 3:00:09 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INSP...
Open
$70.63
High
$71.20
Low
$67.80
Mkt. cap
1.97B
Avg. vol.
855.25K
Volume
796.40K
P/E ratio
14.77
52-wk high
$147.03
52-wk low
$38.91
EPS
$4.61
Beta
0.73
Shares outstanding
28.91M
No. of employees
1K
Open
$70.63
High
$71.20
Low
$67.80
Mkt. cap
1.97B
Avg. vol.
855.25K
Volume
796.40K
P/E ratio
14.77
52-wk high
$147.03
52-wk low
$38.91
EPS
$4.61
Beta
0.73
Shares outstanding
28.91M
No. of employees
1K
News stories
From web sources and news partners
GuruFocus
·
8 hours ago
Inspire Medical Systems (INSP) Prepares to Report Q3 Earnings Am
TradingView
·
9 hours ago
Inspire Medical Systems earnings: what to look for from INSP
About Inspire Medical Systems Inc
Analyst ratings
Based on 15 analysts giving stock ratings to INSP in the past 3 months
Hold
Buy
4
Hold
9
Sell
2
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for INSP in the last 3 months.
Highest
Current $68.10
$97.00 (+42.44%)
Average
$68.64 (+0.79%)
Lowest
$45.00 (-33.92%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Richard Newitter Truist Financial | Hold | Maintained | $78.00 | +14.5% | 10/14/2026 |
Anthony Petrone Mizuho Securities | Buy | Reiterated | $75.00 | +10.1% | 10/13/2026 |
Unknown Analyst Leerink Partners | Hold | Maintained | $67.00 | -1.6% | 10/12/2026 |
Christopher Pasquale Barclays | Sell | Initiated | $65.00 | -4.6% | 10/06/2026 |
Unknown Analyst Barclays | Sell | Initiated | $65.00 | -4.6% | 10/06/2026 |
Adam Maeder Piper Sandler | Hold | Maintained | $60.00 | -11.9% | 10/02/2026 |
Kendall Au RBC Capital | Hold | Maintained | $75.00 | +10.1% | 10/01/2026 |
Shagun Singh Chadha RBC Capital | Hold | Maintained | $75.00 | +10.1% | 10/01/2026 |
Jonathan Block Stifel Nicolaus | Buy | Maintained | $85.00 | +24.8% | 09/22/2026 |
Keith Hinton Freedom Capital Markets | Buy | Reiterated | $97.00 | +42.4% | 09/21/2026 |
Robbie Marcus J.P. Morgan | Hold | Maintained | $60.00 | -11.9% | 08/04/2026 |
Larry Biegelsen Wells Fargo | Hold | Maintained | $56.00 | -17.8% | 08/04/2026 |
Daniel Markowitz CFA Evercore ISI | Hold | Maintained | $54.00 | -20.7% | 08/04/2026 |
Travis Steed Bank of America Securities | Sell | Maintained | $45.00 | -33.9% | 08/04/2026 |
Suraj Kalia Oppenheimer | Buy | Upgraded | $85.00 | +24.8% | 08/04/2026 |
David Rescott Robert W. Baird | Hold | Maintained | $59.00 | -13.4% | 08/04/2026 |
Brett Fishbin KeyBanc | Hold | Maintained | - | - | 08/04/2026 |
Danielle Antalffy UBS | Sell | Downgraded | $39.00 | -42.7% | 07/28/2026 |
Patrick Wood UBS | Sell | Downgraded | $39.00 | -42.7% | 07/28/2026 |
Michael Polark Wolfe Research | Hold | Downgraded | - | - | 02/13/2026 |
Next call in 14:18:40
Tomorrow, 12:00 AM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.09
Revenue / Est. (USD)
- / 204.31M
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 224.50M | 269.08M | 204.58M | 200.58M |
Cost of goods sold | 31.77M | 36.07M | 27.67M | 29.12M |
Cost of revenue | 31.77M | 36.07M | 27.67M | 29.12M |
Research and development expenses | 24.21M | 24.94M | 25.83M | 24.70M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 158.87M | 161.95M | 152.20M | 147.28M |
Operating expense | 183.08M | 186.90M | 178.03M | 171.97M |
Total operating expenses | 214.86M | 222.97M | 205.70M | 201.10M |
Operating income | 9.64M | 46.11M | -1.12M | -514.00K |
Other non operating income | 4.08M | -1.72M | -226.00K | -110.00K |
EBT including unusual items | 13.55M | 50.32M | 2.40M | 3.12M |
EBT excluding unusual items | 17.60M | 46.27M | 2.40M | 3.12M |
Income tax expense | 3.62M | -85.77M | 13.69M | 2.80M |
Effective tax rate | 26.71% | -170.45% | 571.17% | 89.92% |
Other operating expenses | - | - | - | - |
Net income | 9.93M | 136.09M | -11.29M | 314.00K |
Net profit margin | 4.42% | 50.58% | -5.52% | 0.16% |
Earnings per share | 0.38 | 1.65 | 0.10 | 0.14 |
Interest and investment income | 3.98M | 4.00M | 3.74M | 3.74M |
Interest expense | -11.00K | -122.00K | - | - |
Net interest expenses | 3.97M | 3.88M | 3.74M | 3.74M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 13.32M | 49.93M | 3.99M | 4.08M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events